Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
FDA Crackdown on Compounded GLP-1s In February 2026, the FDA announced enforcement action against telehealth companies and compounding pharmacies marketing non-FDA-approved GLP-1 formulations
For Canadians seeking weight loss medications now, tirzepatide (Mounjaro/Zepbound) received Health Canada approval in 2024 and offers similar dual-receptor agonism
Improved Mood and Focus: Adequate B12 levels are associated with better cognitive function and mood regulation
The study population was properly matched with the control group (Table 1) and no significative differences were reported between the two groups
US$ 20.16
US$ 21.86
US$ 20.94
